MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Motor phenotype and disease burden among Parkinson’s disease patients of Addis Ababa, Ethiopia.

    B. Getahun, H. Demissie, H. Nuri, S. Gugssa (Dire Dawa, Ethiopia)

    Objective: This study aims to characterize the motor phenotype of Parkinson’s disease (PD), compare disease severity and to determine quality of life among the different…
  • 2023 International Congress

    Subthalamic Nucleus Deep Brain Stimulation in GBA-associated Parkinson Disease: Cognitive and motor follow-up of two clinical cases

    I. Carvalho, D. Damas, I. Cunha, S. Caldeira, P. Monteiro, R. Pereira, F. Moreira (Coimbra, Portugal)

    Objective: To report the long-term motor and cognitive outcome of two patients with GBA-associated Parkinson’s disease (PD) who underwent STN-DBS surgery. Background: Recent studies suggest…
  • 2023 International Congress

    Identification of xylopropamine as a potential dopamine D2 receptor agonist through computational drug discovery pipeline

    B. Ugbedeojo, P. Adoyi, A. Abah, O. Onimisi, S. Musa, A. Omoniyi (Zaria, Nigeria)

    Objective: This study aims to identify novel dopamine D2 receptor agonists through the computational drug discovery pipeline. Background: Parkinson's disease (PD) is a neurodegenerative disorder…
  • 2023 International Congress

    Cognitive overlap between Parkinson disease (PD) and Alzheimer’s disease (AD) is associated with plasma biomarkers and their impact on regional cortical thickness (CT): An ONDRI Study

    M. Masellis, G. Coughlan, P. Zhukovsky, E. Sanchez, D. Munoz, R. Buckley, T. Steeves, P. Mclaughlin, D. Grimes, M. Jog, C. Marras, H. Zetterberg, H. Kvartsberg, M. Binns, SE. Black, AE. Lang (Toronto, Canada)

    Objective: To investigate cognitive performance across the Parkinson-Alzheimer’s spectrum and its association with plasma biomarkers and regional CT. Background: While PD and AD are neurodegenerative…
  • 2023 International Congress

    The predictive potential of circular walking in prodromal Parkinson’s disease

    ME. Micó-Amigo, I. Kingma, S. Heinzel, S. Solbrig, MA. Hobert, M. Elshehabi, K. Brockmann, FG. Metzger, R. van Lummel, D. Berg, W. Maetzler, JH. van Dieen (Edinburgh, United Kingdom)

    Objective: This study aims to provide quantitative markers of prodromal motor symptoms of idiopathic Parkinson’s disease (PD) from circular walking assessment with a single body-fixed-sensor.…
  • 2023 International Congress

    Factors influencing voice function after deep brain stimulation in Parkinson’s disease

    H. Jergas, T. Tsuboi, V. Stopic, D. Nakatsubo, C. Hennen, S. Maesawa, J. Einhaus, R. Saito, V. Visser-Vandewalle, M. Katsuno, M. Barbe (Cologne, Germany)

    Objective: To assess the effect of Deep Brain Stimulation (DBS) on self-perceived changes of voice function in Parkinson’s disease (PD). Background: To date, the effect…
  • 2023 International Congress

    A cross regional investigation into the effects of fractures on the quality of life for elderly people with Parkinson’s disease in rural India

    S. Kuanar, C. Mahapatra (Bhubaneswar, India)

    Objective: The negative impact of Parkinson’s Disease (PD) is rising as the global population ages and fractures with PD are additional health burdens. In rural…
  • 2023 International Congress

    Understanding the Mechanisms of Brain Dysfunction when Performing the Mental Rotation Task (MRT) in Stage 1 and Stage 2 EOPD using brain imaging

    J. Razzaque, B. Mullen, C. Dougherty, A. Cotton, D. Wagner, S. Ravi, K. Le, K. Iyer, M. Subramanian, J. Wang, K. Venkiteswaran, T. Subramanian, P. Eslinger (Toledo, USA)

    Objective: Our aim is to understand MRT abnormalities in PD using fMRI and whether it can be used as a clinical marker for disease progression…
  • 2023 International Congress

    Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.

    MAG. Medrano-Delgado, DR. Aguila-Godinez, MF. Ruiz-Mafud, LG. Lira-Juárez, EC. Santiago Delacruz, A. Domínguez-García, AJ. Hernández-Medrano, AY. Regalado-Mustafá, MF. Medina-Pérez, G. Hernandez-Armesto, K. Talavera-Laguna, A. Herrera-Ruiz, J. García-Hernández, DP. Romero-Terán, A. Alcocer-Salas, G. Cerda-Hernández, A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga (Ciudad de Mexico, Mexico)

    Objective: to determine the Impact of non-pharmacological strategies on progression in Parkinson's Disease and Cognitive Impairment. Background: PD is the second most common neurodegenerative disorder,…
  • 2023 International Congress

    High Intensity Interval Training for people with Parkinson’s disease: individual response patterns of (non-)motor symptoms and blood-based biomarkers – a crossover single-case experimental design

    E. van Wegen, E. Amaral-Gomez, M. Rietberg, V. de Groot, M. Hirsch, T. Vanbellingen, W. Vanden Berg, O. Vanden Heuvel, C. Vriend (Amsterdam, Netherlands)

    Objective: To quantify individual response patterns of motor symptoms to alternating exercise modalities, along non-motor functioning and blood biomarkers of neuroplasticity and neurodegeneration. Background: Physical…
  • « Previous Page
  • 1
  • …
  • 104
  • 105
  • 106
  • 107
  • 108
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley